Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure

E. Scott Monrad, D. S. Baim, H. S. Smith, A. Lanoue, E. Brauwald, W. Grossman

Research output: Contribution to journalArticle

144 Citations (Scopus)

Abstract

To examine the effect of milrinone on myocardial energetics in patients with congestive heart failure, we measured systemic, pulmonary, and coronary hemodynamics in 18 patients before and after intravenous administration of milrinone (125 ± 36 μg/kg). There was a 45% increase in cardiac index (2.1 ± 0.5 to 3.0 ± 0.6 liters/min/m2, p = .0001), a 39% fall in the pulmonary capillary wedge pressure (28 ± 8 to 17 ± 8 mm Hg; p = .0001), and a 42% increase in left ventricular external work (3758 ± 1419 to 5340 ± 1598 g-m/min; p = .0001). Both the heart rate-blood pressure product (9624 ± 2272 to 9380 ± 2428 mm Hg-beats/min; p = NS) and regional left ventricular myocardial oxygen consumption (7.6 ± 2.9 to 8.1 ± 3.1 ml O2/min; p = NS) were unchanged after milrinone, resulting in a 45% increase in calculated left ventricular external efficiency (p = .004). Although myocardial oxygen consumption did not change, regional great cardiac venous blood flow increased significantly (73 ± 32 to 85 ± 34 ml/min; p = .02) as a result of a 30% reduction in regional coronary vascular resistance (1.32 ± 0.99 to 0.93 ± 0.54 mm Hg-min/ml; p = .004), a decrease comparable to the concurrent 37% and 38% falls seen in systemic and pulmonary vascular resistances, respectively. These changes were associated with an 11% fall in the transcoronary arterial-venous oxygen difference (111 ± 24 to 99 ± 21 ml/O2/liter; p = .0001), which is consistent with a primary coronary vasodilator effect of milrinone. Thus, milrinone enhances cardiac performance without a systematic increase in myocardial oxygen consumption, i.e., it increases left ventricular external efficiency. Furthermore, milrinone may improve coronary flow reserve by direct coronary vasodilation and/or reduction in left ventricular diastolic pressure.

Original languageEnglish (US)
Pages (from-to)972-979
Number of pages8
JournalCirculation
Volume71
Issue number5
StatePublished - 1985
Externally publishedYes

Fingerprint

Milrinone
Heart Failure
Hemodynamics
Oxygen Consumption
Vascular Resistance
Blood Pressure
Pulmonary Wedge Pressure
Ventricular Pressure
Vasodilator Agents
Vasodilation
Intravenous Administration
Heart Rate
Oxygen
Lung

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Monrad, E. S., Baim, D. S., Smith, H. S., Lanoue, A., Brauwald, E., & Grossman, W. (1985). Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. Circulation, 71(5), 972-979.

Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. / Monrad, E. Scott; Baim, D. S.; Smith, H. S.; Lanoue, A.; Brauwald, E.; Grossman, W.

In: Circulation, Vol. 71, No. 5, 1985, p. 972-979.

Research output: Contribution to journalArticle

Monrad, ES, Baim, DS, Smith, HS, Lanoue, A, Brauwald, E & Grossman, W 1985, 'Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure', Circulation, vol. 71, no. 5, pp. 972-979.
Monrad, E. Scott ; Baim, D. S. ; Smith, H. S. ; Lanoue, A. ; Brauwald, E. ; Grossman, W. / Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. In: Circulation. 1985 ; Vol. 71, No. 5. pp. 972-979.
@article{61047a00347246b78325c1cdeaf565a6,
title = "Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure",
abstract = "To examine the effect of milrinone on myocardial energetics in patients with congestive heart failure, we measured systemic, pulmonary, and coronary hemodynamics in 18 patients before and after intravenous administration of milrinone (125 ± 36 μg/kg). There was a 45{\%} increase in cardiac index (2.1 ± 0.5 to 3.0 ± 0.6 liters/min/m2, p = .0001), a 39{\%} fall in the pulmonary capillary wedge pressure (28 ± 8 to 17 ± 8 mm Hg; p = .0001), and a 42{\%} increase in left ventricular external work (3758 ± 1419 to 5340 ± 1598 g-m/min; p = .0001). Both the heart rate-blood pressure product (9624 ± 2272 to 9380 ± 2428 mm Hg-beats/min; p = NS) and regional left ventricular myocardial oxygen consumption (7.6 ± 2.9 to 8.1 ± 3.1 ml O2/min; p = NS) were unchanged after milrinone, resulting in a 45{\%} increase in calculated left ventricular external efficiency (p = .004). Although myocardial oxygen consumption did not change, regional great cardiac venous blood flow increased significantly (73 ± 32 to 85 ± 34 ml/min; p = .02) as a result of a 30{\%} reduction in regional coronary vascular resistance (1.32 ± 0.99 to 0.93 ± 0.54 mm Hg-min/ml; p = .004), a decrease comparable to the concurrent 37{\%} and 38{\%} falls seen in systemic and pulmonary vascular resistances, respectively. These changes were associated with an 11{\%} fall in the transcoronary arterial-venous oxygen difference (111 ± 24 to 99 ± 21 ml/O2/liter; p = .0001), which is consistent with a primary coronary vasodilator effect of milrinone. Thus, milrinone enhances cardiac performance without a systematic increase in myocardial oxygen consumption, i.e., it increases left ventricular external efficiency. Furthermore, milrinone may improve coronary flow reserve by direct coronary vasodilation and/or reduction in left ventricular diastolic pressure.",
author = "Monrad, {E. Scott} and Baim, {D. S.} and Smith, {H. S.} and A. Lanoue and E. Brauwald and W. Grossman",
year = "1985",
language = "English (US)",
volume = "71",
pages = "972--979",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure

AU - Monrad, E. Scott

AU - Baim, D. S.

AU - Smith, H. S.

AU - Lanoue, A.

AU - Brauwald, E.

AU - Grossman, W.

PY - 1985

Y1 - 1985

N2 - To examine the effect of milrinone on myocardial energetics in patients with congestive heart failure, we measured systemic, pulmonary, and coronary hemodynamics in 18 patients before and after intravenous administration of milrinone (125 ± 36 μg/kg). There was a 45% increase in cardiac index (2.1 ± 0.5 to 3.0 ± 0.6 liters/min/m2, p = .0001), a 39% fall in the pulmonary capillary wedge pressure (28 ± 8 to 17 ± 8 mm Hg; p = .0001), and a 42% increase in left ventricular external work (3758 ± 1419 to 5340 ± 1598 g-m/min; p = .0001). Both the heart rate-blood pressure product (9624 ± 2272 to 9380 ± 2428 mm Hg-beats/min; p = NS) and regional left ventricular myocardial oxygen consumption (7.6 ± 2.9 to 8.1 ± 3.1 ml O2/min; p = NS) were unchanged after milrinone, resulting in a 45% increase in calculated left ventricular external efficiency (p = .004). Although myocardial oxygen consumption did not change, regional great cardiac venous blood flow increased significantly (73 ± 32 to 85 ± 34 ml/min; p = .02) as a result of a 30% reduction in regional coronary vascular resistance (1.32 ± 0.99 to 0.93 ± 0.54 mm Hg-min/ml; p = .004), a decrease comparable to the concurrent 37% and 38% falls seen in systemic and pulmonary vascular resistances, respectively. These changes were associated with an 11% fall in the transcoronary arterial-venous oxygen difference (111 ± 24 to 99 ± 21 ml/O2/liter; p = .0001), which is consistent with a primary coronary vasodilator effect of milrinone. Thus, milrinone enhances cardiac performance without a systematic increase in myocardial oxygen consumption, i.e., it increases left ventricular external efficiency. Furthermore, milrinone may improve coronary flow reserve by direct coronary vasodilation and/or reduction in left ventricular diastolic pressure.

AB - To examine the effect of milrinone on myocardial energetics in patients with congestive heart failure, we measured systemic, pulmonary, and coronary hemodynamics in 18 patients before and after intravenous administration of milrinone (125 ± 36 μg/kg). There was a 45% increase in cardiac index (2.1 ± 0.5 to 3.0 ± 0.6 liters/min/m2, p = .0001), a 39% fall in the pulmonary capillary wedge pressure (28 ± 8 to 17 ± 8 mm Hg; p = .0001), and a 42% increase in left ventricular external work (3758 ± 1419 to 5340 ± 1598 g-m/min; p = .0001). Both the heart rate-blood pressure product (9624 ± 2272 to 9380 ± 2428 mm Hg-beats/min; p = NS) and regional left ventricular myocardial oxygen consumption (7.6 ± 2.9 to 8.1 ± 3.1 ml O2/min; p = NS) were unchanged after milrinone, resulting in a 45% increase in calculated left ventricular external efficiency (p = .004). Although myocardial oxygen consumption did not change, regional great cardiac venous blood flow increased significantly (73 ± 32 to 85 ± 34 ml/min; p = .02) as a result of a 30% reduction in regional coronary vascular resistance (1.32 ± 0.99 to 0.93 ± 0.54 mm Hg-min/ml; p = .004), a decrease comparable to the concurrent 37% and 38% falls seen in systemic and pulmonary vascular resistances, respectively. These changes were associated with an 11% fall in the transcoronary arterial-venous oxygen difference (111 ± 24 to 99 ± 21 ml/O2/liter; p = .0001), which is consistent with a primary coronary vasodilator effect of milrinone. Thus, milrinone enhances cardiac performance without a systematic increase in myocardial oxygen consumption, i.e., it increases left ventricular external efficiency. Furthermore, milrinone may improve coronary flow reserve by direct coronary vasodilation and/or reduction in left ventricular diastolic pressure.

UR - http://www.scopus.com/inward/record.url?scp=0021837332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021837332&partnerID=8YFLogxK

M3 - Article

C2 - 3986984

AN - SCOPUS:0021837332

VL - 71

SP - 972

EP - 979

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 5

ER -